3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
42
Precursor Cell Lymphoblastic Leukemia-Lymphoma
33
Lymphoma, Large B-Cell, Diffuse
29
Lymphoma, Follicular
15
Lymphoma, Non-Hodgkin
13
Leukemia
11
Hodgkin Disease
11
Burkitt Lymphoma
10
Leukemia, Biphenotypic, Acute
7
Recurrence
6
Lymphoma, Large-Cell, Anaplastic
6
Lymphoma, B-Cell
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Immunoblastic Lymphadenopathy
4
Dendritic Cell Sarcoma, Interdigitating
4
Neoplasms
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, B-Cell, Marginal Zone
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neurotoxicity Syndromes
2
Neoplasm, Residual
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Enteropathy-Associated T-Cell Lymphoma
2
Down Syndrome
2
Vomiting
1
Pulmonary Disease, Chronic Obstructive
1
Philadelphia Chromosome
1
Interventions
Tiotropium Bromide
1
Salmeterol Xinafoate
1
Prednisolone
1
Fluticasone-Salmeterol Drug Combination
1
Fluticasone
1
Exercise
1
Albuterol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pulmonary Disease, Chronic Obstructive
×
Prednisolone
×
Lymphoid
×
Clear all
NCT00555607
2021-03-03
BIOAIR
Karolinska Institutet
Phase NA
Active not recruiting
233 enrolled